Close Menu

This story has been updated from a previous version to include a statement from a University of California spokesperson.

NEW YORK – In the fight between the Broad Institute and the University of California, Berkeley for the bulk of the intellectual property rights to CRISPR-Cas9 technology, the United States Patent and Trademark Office's Patent Trial and Appeal Board (PTAB) issued a new ruling this week that may have given the Broad the definitive upper hand.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.